RecruitingPhase 3NCT07221851
Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders
Sponsor: Ascendis Pharma A/S
Lake Success, NY · +22 more sites